Report copyright - Phase III CORRECT trial of regorafenib in metastatic ...kanser.org/saglik/upload/malign_pdf2/Phase_III_CORRECT...Regorafenib (BAY 73-4506), an oral multikinase inhibitor targeting
Please pass captcha verification before submit form